The Claim
Intensive systolic blood pressure control has a consistent relative benefit on major adverse cardiovascular events and all-cause mortality across the full spectrum of frailty, with no statistically significant interaction between frailty level and treatment effect.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Intensive control of systolic blood pressure reduces major adverse cardiovascular events and death at the same relative rate in people who are not frail, mildly frail, or severely frail.
See the scientific wording
The relative benefit of intensive systolic blood pressure control on major adverse cardiovascular events and all-cause mortality is consistent across the full spectrum of frailty, from nonfrail to severely frail, with no statistically significant interaction (P=0.67 for MACE, P=0.21 for death).
Lowering systolic blood pressure reduces the force pushing against artery walls, which prevents tiny tears in the lining of blood vessels and slows the hardening of arteries. This keeps plaques stable and ensures organs like the heart and brain get enough blood without sudden blockages.
What the research says
1 studyEven very frail older adults benefited just as much from lowering their blood pressure to below 120 as healthier people did — they had fewer heart attacks, strokes, and deaths, without more dangerous side effects.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.